Abstract: There is provided a liquid crystal display structure including a display unit, a lower frame and a twin adhesive tape. The lower frame includes a bottom plate and a sidewall, wherein the sidewall perpendicularly extends upward from edges of the bottom plate and has an opening. The twin adhesive tape is adhered to the bottom plate of the lower frame inside the sidewall and is configured to combine the display unit with the bottom plate, wherein the twin adhesive tape has an extended part extending out from the opening of the sidewall.

Abstract: The display apparatus includes a backlight module, which includes a light source, a light-emitting surface, a light-emitting counter surface and a flexible circuit. The light-emitting counter surface is disposed opposite to the light-emitting surface. The flexible circuit is electrically connected with the light source, and has a portion covering the light-emitting counter surface.

Abstract: A liquid crystal lens is disclosed, comprising a plurality of lens units, wherein each lens unit comprises a first substrate, a second substrate opposite to the first substrate, a liquid crystal layer disposed between the first substrate and the second substrate, an insulating layer disposed on the first substrate, and a first electrode and a first floating electrode disposed at opposite sides of the insulating layer, wherein the first electrode comprises a first portion neighboring a first side of the lens unit and a second portion neighboring a second side of the lens unit, and the first floating electrode comprises a first portion and a second portion, wherein the first portion of the first floating electrode is partially overlapped with the first portion of the first electrode, and the second portion of the first floating electrode is partially overlapped with the second portion of the first electrode

Abstract: Provided herein are methods, compounds, and compositions for reducing expression of fibroblast growth factor receptor 4 (FGFR4) mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease, or a symptom thereof.

Abstract: Methods are provided for modulating RBP4 by administering a RBP4-specific modulator. Also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of RBP4. The present invention is also directed to methods of decreasing lipid levels in a subject or for preventing or delaying the onset of a rise in lipid levels in a subject, comprising administering to said subject a RBP4-specific inhibitor.

Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.

Abstract: Disclosed herein are compounds, compositions and methods for modulating DGAT-1 activity. Preferably, the expression of DGAT-1 from a nucleic acid is inhibited. Methods are provided for treating, ameliorating or treating liver fibrosis, either directly or by treating an underlying etiological factor. Preferably, the treatment, amelioration or prevention comprises administering a DGAT-1 activity modulator.

Abstract: Compounds, compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding diacylglycerol acyltransferase 2. Methods of using these compounds for modulation of diacylglycerol acyltransferase 2 expression and for diagnosis and treatment of diseases and conditions associated with expression of diacylglycerol acyltransferase 2 are provided.

Abstract: A radiation structure without a light guiding board for a backlight module or an illuminant device includes an optical plate formed with at least one rising area having a rising surface defined at the center thereof, two light sources disposed adjacent to two sides of the optical plate, and a diffusion plate. The light sources each possess a radiant half-intensity angle below 15 degrees for respectively forming optic axial directions thereof, allowing a radiation field to be diffusively formed from the pivoting of the optic axial directions. Whereby, the optic axial directions respectively face toward the rising surface, allowing the projection of the radiation field on the rising surface, and the diffusion plate is disposed above the rising area of the optical plate. Therefore, an even radiating surface caused by a diffusion of the light sources from the diffusion plate could be preferably obtained even if no light guiding board is applied.

Abstract: Compounds, compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding diacylglycerol acyltransferase 2. Methods of using these compounds for modulation of diacylglycerol acyltransferase 2 expression and for diagnosis and treatment of diseases and conditions associated with expression of diacylglycerol acyltransferase 2 are provided.

Abstract: The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal kinase 1 (JNK1 protein.

Abstract: The display apparatus includes a backlight module, which includes a light source, a light-emitting surface, a light-emitting counter surface and a flexible circuit. The light-emitting counter surface is disposed opposite to the light-emitting surface. The flexible circuit is electrically connected with the light source, and has a portion covering the light-emitting counter surface.

Abstract: A backlight module and a display apparatus are disclosed. The backlight module comprises a frame, a plurality of light guide units and a plurality of light sources. The frame includes an inside surface and a plurality of positioning convex portions, wherein the positioning convex portions are formed on the inside surface. The light guide units are disposed in the frame and have a plurality of positioning concave portions. The positioning convex portions of the frame correspond to the positioning concave portions of the light guide units, thereby positioning the light guide units in the frame. The light sources are disposed at one side of the light guide units. The backlight module is applicable to the display apparatus.

Abstract: Disclosed herein are compounds, compositions and methods for modulating DGAT-1 activity. Preferably, the expression of DGAT-1 from a nucleic acid is inhibited. Methods are provided for treating, ameliorating or treating liver fibrosis, either directly or by treating an underlying etiological factor. Preferably, the treatment, amelioration or prevention comprises administering a DGAT-1 activity modulator.

Abstract: The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal kinase 1 (JNK1 protein.

Abstract: A radiation structure without a light guiding board for a backlight module or an illuminant device includes an optical plate formed with at least one rising area having a rising surface defined at the center thereof, two light sources disposed adjacent to two sides of the optical plate, and a diffusion plate. The light sources each possess a radiant half-intensity angle below 15 degrees for respectively forming optic axial directions thereof, allowing a radiation field to be diffusively formed from the pivoting of the optic axial directions. Whereby, the optic axial directions respectively face toward the rising surface, allowing the projection of the radiation field on the rising surface, and the diffusion plate is disposed above the rising area of the optical plate. Therefore, an even radiating surface caused by a diffusion of the light sources from the diffusion plate could be preferably obtained even if no light guiding board is applied.

Abstract: Disclosed herein are compounds, compositions and methods for modulating DGAT-1 activity. Preferably, the expression of DGAT-1 from a nucleic acid is inhibited. Methods are provided for treating, ameliorating or treating liver fibrosis, either directly or by treating an underlying etiological factor. Preferably, the treatment, amelioration or prevention comprises administering a DGAT-1 activity modulator.

Abstract: Methods are provided for modulating CREB by administering a CREB-specific modulator. Also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of CREB. The present invention is also directed to methods of decreasing lipid levels in a subject or for preventing or delaying the onset of a rise in lipid levels in a subject, comprising administering to said subject a CREB-specific inhibitor.

Abstract: Methods are provided for modulating RBP4 by administering a RBP4-specific modulator. Also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of RBP4. The present invention is also directed to methods of decreasing lipid levels in a subject or for preventing or delaying the onset of a rise in lipid levels in a subject, comprising administering to said subject a RBP4-specific inhibitor.

Abstract: A light emitting unit includes a light bar set, a connecting mechanism and a closed-loop terminal. The light bar set includes a plurality of light bars, wherein each light bar includes a plurality of light emitting elements and a circuit board, and the light emitting elements are disposed on the circuit board. The connecting mechanism includes a plurality of connecting elements for electrically connecting the first one to the last one of the light bars in order. The connecting mechanism has a front end and a rear end. The closed-loop terminal is electrically connected to the rear end of the connecting mechanism, whereby the light bar set, the connecting mechanism and the closed-loop terminal are formed to a closed loop.